会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Gold complexes for use in the treatment of cancer
    • 用于治疗癌症的金配合物
    • US09346832B2
    • 2016-05-24
    • US13704894
    • 2011-06-14
    • Orde Quentin MunroKate Julie AkermanPiers Akerman
    • Orde Quentin MunroKate Julie AkermanPiers Akerman
    • C07F1/12A61K31/28C01G7/00C07C209/16C07C213/02C07D401/12C07D487/22C07C209/68C07C209/86C07C213/06C07D207/335
    • C07F1/12C01G7/00C07C209/16C07C209/68C07C209/86C07C213/02C07C213/06C07D207/335C07D401/12C07D487/22C07C211/15C07C217/42
    • The invention provides compounds of the Formula (I), in which W is independently selected from W1, W2, W3, W4, W5, or W represents a pair of substituents independently selected from H, alkyl, aryl or amide in which the amide is optionally part of a linking chain, and the Zn—Zn′ bonds (n=4-17; n′=n+1) are optionally of any whole or partial bond order, Y is Y1 or Y represents a pair of substituents independently selected from H, C1-C6 alkyl, Z5 or Z6 aryl, or Y is optionally a bridging structure that may comprise one or more C1-C6 amide, C1-C6 ether, or C1-C6 ester groups, R—R39 are independently selected from no substituent, a lone pair of electrons, H, halogen, C5-C6 aryl, C1-C12 alkyl, amine, C1-C6 alkylamine, C1-C6 amide, nitro, cyano, carboxyl, C1-C6 ester, phosphane, thiol, C1-C6 thioether, OR40, and suitable pairs of adjacent R groups (R—R39) may optionally together form part of a C5 or C6 aryl ring, a Z5 or Z6 ring, R40 is independently selected from H, C1-C6 alkyl, Z5 or Z6 aryl, C1-C6 ester, poly(—C2O—), amine, and C1-C6 alkylamine, Z—Z24 are independently selected from C, N, P, O, and S, and X− is a pharmaceutically acceptable anion, for the treatment of cancer.
    • 本发明提供式(I)化合物,其中W独立地选自W 1,W 2,W 3,W 4,W 5或W表示独立地选自H,烷基,芳基或酰胺的一对取代基,其中酰胺是 任选地部分连接链,Zn-Zn'键(n = 4-17; n'= n + 1)任选地具有任何全部或部分键合顺序,Y是Y1或Y表示独立选择的一对取代基 由H,C 1 -C 6烷基,Z 5或Z 6芳基,或Y任选是可以包含一个或多个C 1 -C 6酰胺,C 1 -C 6醚或C 1 -C 6酯基团的桥连结构,R-R 39独立地选自 无取代基,孤对电子,H,卤素,C5-C6芳基,C1-C12烷基,胺,C1-C6烷基胺,C1-C6酰胺,硝基,氰基,羧基,C1-C6酯, C1-C6硫醚,OR40和适当的相邻R基团(R-R39)可以任选地一起形成C5或C6芳基环,Z5或Z6环的一部分,R40独立地选自H,C1-C6烷基, Z5 或Z6芳基,C1-C6酯,聚(-C2O-),胺和C1-C6烷基胺,Z-Z24独立地选自C,N,P,O和S,X-是药学上可接受的阴离子 ,用于治疗癌症。
    • 5. 发明申请
    • CONCENTRATE QUALITY IN THE ENRICHMENT OF UG-2 PLATINUM ORE
    • 浓缩UG-2铂金的浓度
    • US20110229384A1
    • 2011-09-22
    • US13047156
    • 2011-03-14
    • Alexej MICHAILOVSKIImme DomkeFrank BozichDavid F. Blackwood
    • Alexej MICHAILOVSKIImme DomkeFrank BozichDavid F. Blackwood
    • C01G55/00C01G7/00
    • C01G7/00C01G55/00
    • The present invention relates to a process for separating at least one first substance from a mixture comprising this at least one first substance and at least one second substance, comprising the steps of (A) bringing the mixture comprising at least one first substance and at least one second substance into contact with at least one surface-active substance, (B) if required, addition of at least one dispersing medium to the mixture obtained in step (A) in order to obtain a dispersion, and (C) separation of the adduct of at least one first substance and at least one surface-active substance from the dispersion from step (A) or (B), for example by means of flotation, at least one additive which is either a monomolecular compound comprising amino and carboxyl groups or derivatives thereof or a polymeric compound obtainable by reaction of alkylene oxides and/or aziridines, or mixtures thereof, being added to the mixture comprising at least one first substance and at least one second substance.
    • 本发明涉及从包含该至少一种第一物质和至少一种第二物质的混合物中分离出至少一种第一物质的方法,该方法包括以下步骤:(A)将混合物包含至少一种第一物质和至少 一种第二物质与至少一种表面活性物质接触,(B)如果需要,在步骤(A)中获得的混合物中加入至少一种分散介质以获得分散体,和(C)分离 至少一种第一物质和来自步骤(A)或(B)的分散体的至少一种表面活性物质的加合物,例如通过浮选,至少一种作为包含氨基和羧基的单分子化合物的添加剂 或其衍生物或通过环氧烷和/或氮丙啶或其混合物的反应获得的聚合物,其被加入到包含至少一种第一物质和至少一种第二物质的混合物中 ance。